We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

82 hedge funds and large institutions have $76.8M invested in Cytosorbents Corp in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital invested

Capital invested by funds: $34.4M → $76.8M (+$42.4M)

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

14% more funds holding

Funds holding: 72 → 82 (+10)

5% more call options, than puts

Call options by funds: $971K | Put options by funds: $925K

0.82% more ownership

Funds ownership: 27.58% → 28.4% (+0.82%)

Holders
82
Holders Change
+10
Holders Change %
+13.89%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
25
Reduced
18
Closed
11
Calls
$971K
Puts
$925K
Net Calls
+$46K
Net Calls Change
+$105K

Top Buyers

Rank Fund Capital Flow
1
SC
Skylands Capital
Wisconsin
+$1.57M
2
SIG
Sargent Investment Group
Maryland
+$1.03M
3
EI
EAM Investors
California
+$687K
4
MHP
Manatuck Hill Partners
Connecticut
+$631K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$507K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$594K
2
Two Sigma Investments
Two Sigma Investments
New York
-$418K
3
AFM
Anson Funds Management
Texas
-$287K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$195K
5
JP Morgan Chase
JP Morgan Chase
New York
-$154K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$4K -$20K -3,954 -88%
CFD
77
Creative Financial Designs
Indiana
$3K +$1.77K +350 New
PA
78
Parallel Advisors
California
$1K – – –
LC
79
Lindbrook Capital
California
$1K +$631 +125 New
GWMIA
80
Global Wealth Management Investment Advisory
Florida
$1K +$757 +150 New
EI
81
Ellevest Inc
New York
$1K +$767 +152 New
Two Sigma Investments
82
Two Sigma Investments
New York
– -$418K -108,693 Closed
AFM
83
Anson Funds Management
Texas
– -$287K -74,440 Closed
D.E. Shaw & Co
84
D.E. Shaw & Co
New York
– -$195K -50,767 Closed
OGC
85
One68 Global Capital
New York
– -$151K -39,241 Closed
EGM
86
Engineers Gate Manager
New York
– -$83K -21,665 Closed
Squarepoint
87
Squarepoint
New York
– -$77K -20,047 Closed
BFM
88
Boothbay Fund Management
New York
– -$54K -13,944 Closed
MWP
89
MYCIO Wealth Partners
Pennsylvania
– -$50K -12,894 Closed
TRCT
90
Tower Research Capital (TRC)
New York
– -$15K -3,972 Closed
SO
91
STRS Ohio
Ohio
– -$8K -2,300 Closed
Simplex Trading
92
Simplex Trading
Illinois
– -$5.52K -1,094 Closed
1 2 3
4

CTSO Hedge Fund Activity: Q1 2020 in Review

82 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2020, worth a combined $76.8M — up 123% from $34.4M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CTSO positions and 11 closed out — a net gain of 12 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Skylands Capital, adding an estimated $1.57M. The largest seller was Morgan Stanley, cutting an estimated $594K.

  • 82 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2020, up from 72 in Q4 2019.
  • Funds reported $76.8M of Cytosorbents Corp stock for Q1 2020, up 123% quarter-over-quarter.
  • 23 funds opened new Cytosorbents Corp positions in Q1 2020 and 11 closed out, a net change of +12 holders.
  • The largest Cytosorbents Corp buyer in Q1 2020 was Skylands Capital, an estimated $1.57M added.
  • The largest Cytosorbents Corp seller in Q1 2020 was Morgan Stanley, an estimated $594K sold.

Based on aggregated 13F filings for Q1 2020.